Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.690
+0.020 (0.54%)
At close: Apr 28, 2026, 4:00 PM EDT
3.690
0.00 (0.01%)
After-hours: Apr 28, 2026, 7:55 PM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $653.42 million as of April 28, 2026. Its market cap has increased by 284.84% in one year.
Market Cap
653.42M
Enterprise Value
592.17M
1-Year Change
284.84%
Ranking
Category
Stock Price
$3.69
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $653.42M, a decrease of -59.85%. That is a compound annual growth rate of -22.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 653.42M | 6.37% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexicon Pharmaceuticals | 716.02M |
| BridgeBio Oncology Therapeutics | 703.49M |
| Gyre Therapeutics | 696.73M |
| Alpha Tau Medical | 696.16M |
| Arvinas | 658.16M |
| Forte Biosciences | 654.55M |
| First Tracks Biotherapeutics | 628.95M |
| CorMedix | 613.31M |